CLX HEALTH LLC – Trademark Portfolio
Entity Type: 16
CLX HEALTH LLC holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 10 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include YORN, SYMCHECK, SCAN2CLEAR, and CONFIDENCE SERVED HERE.. The owner is based in NEWARK, DE.
200 CONTINENTAL DRIVE, SUITE 401
NEWARK, DE 19713
Showing of trademarks Trademarks
Trademark Classifications
CLX HEALTH LLC's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does CLX HEALTH LLC have?
CLX HEALTH LLC has 11 U.S. trademarks filed with the USPTO. Of these, 4 registered, 2 abandoned, 5 cancelled.
What trademark classes does CLX HEALTH LLC file in?
CLX HEALTH LLC files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 35 (Advertising & Business), Class 9 (Computers & Electronics). Class 42 covers scientific and technological services; industrial analysis and research services.
What are CLX HEALTH LLC's most well-known trademarks?
CLX HEALTH LLC's registered trademark portfolio includes well-known marks such as YORN, SYMCHECK, SCAN2CLEAR, and CONFIDENCE SERVED HERE.. These are among 4 currently registered trademarks in the portfolio.
What is CLX HEALTH LLC's trademark registration success rate?
CLX HEALTH LLC has a 36% trademark registration rate, with 4 out of 11 resolved applications resulting in successful registration. Currently, 0 applications are pending review.